ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1399 National Cancer Institute Html en Nausea and Vomiting Related to Cancer Treatment (PDQ®)–Patient Version Expert-reviewed information summary about nausea and vomiting as complications of cancer or its treatment. Approaches to the management of nausea and vomiting are discussed.
cancer treatment0.379171
chemotherapy session0.416704
past chemotherapy treatments0.404595
motion sickness0.3776
chemotherapy0.552867
PDQ cancer information0.463652
chemotherapy treatment0.441369
late nausea0.506038
anticipatory nausea0.711385
clinical trials0.378644
vomiting0.900093
Vomiting Related0.471509
cancer information summary0.41736
patients0.393418
earlier chemotherapy session0.400031
treatment room0.360635
NCI’s PDQ0.353745
nausea0.98576
NCI PDQ cancer0.3835
radiation therapy0.495467
antinausea drugs0.406187
involuntary body functions0.353798
certain chemotherapy drugs0.416814
following treatment factors0.366128
radiation therapy treatments0.356798
treatment0.558325
gastrointestinal tract0.416866
following table0.366172
delayed nausea0.530808
Cancer Information Service0.360675
following patient factors0.352013
previous chemotherapy sessions0.394908
patient0.370352
treatment clinical trials0.357831
National Cancer Institute0.420163
Palliative Care Editorial0.381728
new treatment0.358991
chronic nausea0.490418
drugs0.426328
Cancer Care page0.352418
Care Editorial Board0.382615
chemotherapy sessions0.400414
PDQ summary0.40058
Nausea section0.481663
cancer information summaries0.360345
comprehensive cancer information0.360198
cancer therapy0.357442
acute nausea0.484601
CLICK HERE
1517 National Cancer Institute Html en Pancreatic Cancer Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of pancreatic cancer.
cancer treatment0.45958
malignant tumor cells0.419406
body0.510954
chemotherapy0.404222
PDQ cancer information0.497348
clinical trial search0.455776
pancreas0.487969
clinical trials0.753194
nearby lymph nodes0.471943
cancer information summary0.460465
clinical trial0.646358
cancer cells0.504208
exocrine pancreatic cancer0.466193
patients0.395936
treatment clinical trial0.39568
endocrine pancreatic cancer0.462275
NCI PDQ cancer0.417319
Pancreatic Cancer Treatment0.455234
Treatment Editorial Board0.392271
small intestine0.597674
endocrine pancreas cells0.397632
general cancer information0.404462
treatment0.608368
general information0.413544
new cancer treatments0.400431
NCI-supported cancer0.412236
Cancer Information Service0.405331
specific cancer cells0.402178
pancreatic cancer0.933074
pancreatic cancer spreads0.442487
stage pancreatic cancer0.467555
treatment clinical trials0.430898
National Cancer Institute0.509295
Pancreatic Neuroendocrine Tumors0.405468
new treatment0.444026
Radiation therapy0.523817
Blood. The cancer0.396713
PDQ summary0.454317
cancer research process0.390975
cancer clinical trials0.486763
tumor0.448545
high-energy sound waves0.434518
cancer information summaries0.402821
comprehensive cancer information0.402789
internal radiation therapy0.390099
cancer0.947965
information0.519314
standard treatment0.39251
Recurrent pancreatic cancer0.47605
CLICK HERE
1546 National Cancer Institute Html en AIDS-Related Lymphoma Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of AIDS-Related Lymphoma.
cancer treatment0.383886
AIDS-Related Lymphoma Treatment0.393286
cancer spreads0.326687
malignant tumor cells0.309541
body0.433918
chemotherapy0.309155
PDQ cancer information0.394743
clinical trial search0.3032
white blood cells0.3776
clinical trials0.731846
cancer information summary0.354741
clinical trial0.454136
AIDS-related peripheral/systemic lymphoma0.466219
patients0.380662
blood cells0.399358
old blood cells0.295369
AIDS-related lymphomas0.315773
treatment clinical trial0.296684
NCI PDQ cancer0.309251
lymph nodes0.464743
large B-cell lymphoma0.331734
radiation therapy0.344733
Treatment Editorial Board0.312981
lymph node groups0.478813
treatment0.574951
swollen lymph nodes0.339153
cancer cells0.476016
lymph node group0.321747
specific cancer cells0.306685
AIDS-related non-Hodgkin lymphoma0.392687
primary cns lymphoma0.430113
treatment clinical trials0.33124
National Cancer Institute0.355357
aids-related lymphoma0.927549
lymph vessels0.351707
new treatment0.337577
External radiation therapy0.327164
B-cell immunoblastic lymphoma0.332379
AIDS-related primary CNS0.358458
bone marrow0.523968
cancer clinical trials0.341952
stage0.313358
treatment options0.307053
nervous system lymphoma0.295273
cancer0.766753
standard treatment0.309541
lymph tissue0.333823
body lymphoma0.323497
Burkitt-like lymphoma0.311372
CLICK HERE
1585 National Cancer Institute Html en Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)–Patient Version Multiple myeloma, plasmacytoma, lymphoplasmacytic lymphoma, and monoclonal gammopathy of undetermined significance (MGUS) are different types of plasma cell neoplasms. Find out about risk factors, symptoms, tests to diagnose, prognosis, stages, and treatment for these diseases.
red blood cells0.474629
myeloma cells0.443938
cancer treatment0.407402
Myeloma treatment options0.373753
biologic therapy0.382101
blood -forming cells0.372128
body0.40943
type0.393577
PDQ cancer information0.415525
bone marrow aspiration0.378402
clinical trial search0.419003
white blood cells0.422631
clinical trials0.689828
mature blood cells0.378353
abnormal plasma cells0.479263
cancer information summary0.39289
clinical trial0.492432
stem cells0.378
multiple myeloma0.975001
patients0.39195
blood cells0.516713
plasma cell neoplasm0.43097
radiation therapy0.450659
Treatment Editorial Board0.365249
General information0.366352
treatment0.57038
skeletal bone survey0.42368
immature blood cells0.371472
plasma cell tumor0.384236
NCI-supported cancer0.3737
cancer cells0.440163
normal blood cells0.369334
specific cancer cells0.38023
diagnose multiple myeloma0.381187
patient0.372697
treatment clinical trials0.388849
National Cancer Institute0.392841
initial treatment0.372799
new treatment0.406543
plasma cells0.480204
refractory multiple myeloma0.365057
bone marrow0.582695
healthy blood cells0.378266
cells0.557939
cancer clinical trials0.42623
cancer0.627272
information0.418087
myeloma cells increases0.397071
plasma cell neoplasms0.895903
CLICK HERE
1621 National Cancer Institute Html en Ewing Sarcoma Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of Ewing sarcoma.
cancer treatment0.289749
malignant tumor cells0.276208
soft tissue0.253817
body0.332426
type0.219713
chemotherapy0.237331
treatments0.202586
PDQ cancer information0.292839
clinical trial search0.246556
extraosseous Ewing sarcoma0.264218
Ewing sarcoma spreads0.243807
clinical trials0.704097
Pediatric Treatment Editorial0.209616
nearby lymph nodes0.208892
cancer information summary0.25517
clinical trial0.374839
recurrent Ewing sarcoma0.335434
stage Ewing sarcoma0.262403
patients0.209976
Soft Tissue Sarcoma0.20334
childhood Ewing sarcoma0.227663
CAR T-cell therapy0.238653
NCI PDQ cancer0.207565
Ewing sarcoma family0.264166
radiation therapy0.525383
Treatment Editorial Board0.214583
treatment0.586815
Ewing sarcoma0.925686
Ewing sarcoma cells0.277555
NCI-supported cancer0.206887
cancer cells0.457951
metastatic Ewing sarcoma0.365401
specific cancer cells0.219988
patient0.217481
treatment clinical trials0.236708
National Cancer Institute0.256904
initial treatment0.212474
effects cancer treatment0.221598
new treatment0.271508
bone0.246041
metastatic tumor0.210193
bone marrow0.235686
Ewing tumor0.226375
cancer clinical trials0.279951
stem cell rescue0.32512
tumor0.434783
High-dose chemotherapy0.218893
cancer0.820936
standard treatment0.227171
CLICK HERE
1638 National Cancer Institute Html en Essiac/Flor Essence (PDQ®)–Patient Version Essiac and Flor Essence are herbal tea mixtures first developed in Canada that are thought to remove toxins and poisons from the body and strengthen the immune system, although this has not been proven in cancer patients. Read about the history of Essiac and Flor Essence, the theory behind its use, and the results of laboratory, animal, and human studies.
Essiac formula0.502569
peer-reviewed scientific journals0.490423
cancer treatment0.454247
cancer prevention0.375568
Complementary Therapies Editorial0.416551
Kill cancer cells0.376017
breast cancer patient0.382628
Drug Administration0.400504
Cancer Information Specialist0.387931
Flor Essence0.977313
Flor Essence state0.48205
herbal dietary supplements0.446297
Flor Essence formulas0.482148
Cancer Information Service0.448298
Essiac0.851494
Essiac herbal teas0.514938
PDQ cancer information0.515287
health tonics0.425459
Cancer Complementary0.397385
Flor Essence products0.478002
CAM therapies0.376991
prostate cancer cells0.376887
Flor Essence tea0.479505
National Cancer Institute0.598699
studies0.410222
Sloan-Kettering Cancer Center0.381887
clinical trials0.491591
Royal Cancer Commission0.384396
alternative medicine0.441037
health care0.376403
cancer information summary0.466243
alternative cancer therapies0.394811
Federal Trade Commission0.379856
clinical trial0.417042
cancer cells0.389663
Essiac/Flor Essence0.431725
CAM cancer research0.383472
herbal tea mixtures0.394707
cancer patients0.424798
NCI PDQ cancer0.416273
cancer information database0.392781
effects0.382227
alternative therapies0.415163
cancer information summaries0.394001
Therapies Editorial Board0.400185
cancer0.660273
research studies0.398662
CLICK HERE
1644 National Cancer Institute Html en Gerson Therapy (PDQ®)–Patient Version Expert-reviewed information summary about the use of the Gerson therapy as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.
treatment0.476929
cancer treatment0.426084
cancer prevention0.384318
Complementary Therapies Editorial0.435586
Cancer Information Specialist0.399657
Drug Administration0.382514
body0.378493
Cancer Information Service0.518118
PDQ cancer information0.525476
Cancer Complementary0.410407
CAM therapies0.388339
Gerson’s therapy0.456461
treatment clinical trials0.381128
Gerson therapy reports0.478587
National Cancer Institute0.663474
clinical trials0.562754
Dr. Gerson0.569329
alternative medicine0.46145
health care providers0.421555
health care0.444706
cancer information summary0.471527
Max B. Gerson0.46509
Gerson Research Organization0.453179
alternative cancer therapies0.404484
Federal Trade Commission0.391653
National Institutes0.385207
clinical trial0.399404
National Center0.376357
CAM cancer research0.391227
new treatment0.374685
breast cancer prevention0.381892
patients0.477683
cancer patients0.443285
Cancer Care page0.385186
latest published information0.376378
key parts0.39704
NCI’s PDQ0.381863
PDQ summary0.408051
Integrative Health0.376266
NCI PDQ cancer0.437412
cancer information database0.407023
alternative therapies0.430873
cancer information summaries0.407395
Therapies Editorial Board0.414248
cancer0.692284
gerson therapy0.948648
cancer information0.545756
CLICK HERE
1685 National Cancer Institute Html en Cannabis and Cannabinoids (PDQ®)–Health Professional Version Expert-reviewed information summary about the use of Cannabis and cannabinoids in the treatment of cancer-related side effects, such as nausea and vomiting.
cannabinoid receptor CB20.721549
cancer cell proliferation0.723514
opioid-treated cancer patients0.721253
lung cancer0.774703
testicular germ cell0.736506
Cannabis trials0.713054
endogenous cannabinoids0.733591
bladder cancer0.72104
clinical trials0.71653
cannabinoid receptors0.745589
advanced cancer patients0.745457
CBD oromucosal spray0.730536
cancer cell invasiveness0.726743
Cancer Res0.716198
cancer patients0.801404
Investigational New Drug0.714731
non-small cell lung0.751006
effects0.733811
colorectal cancer cell0.727697
cancer chemotherapy0.737056
cannabinoids0.838589
et al.0.767053
treatment0.713465
study0.761272
CBD0.77215
United States0.780596
Cannabis plant0.728018
orally administered Cannabis0.721336
Cancer Epidemiol Biomarkers0.717008
cancer cell lines0.803788
cannabinoid receptor0.74565
THC0.76674
Cannabis extract0.739506
lung cancer chemotherapy0.709535
cancer cell invasion0.72445
breast cancer cell0.789227
Cancer pain results0.7118
cancer pain0.721348
open-label extension study0.709343
advanced cancer0.748132
cell death0.806928
Abstract0.744659
cannabis0.92504
germ cell tumors0.735413
medicinal Cannabis0.751597
cell lung cancer0.728336
Cannabis species0.726958
cancer0.952946
Guidelines recommend cannabinoids0.714742
CLICK HERE
2111 National Cancer Institute Html es Exámenes de detección del cáncer de esófago (PDQ®)–Versión para pacientes Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de esófago.
PDQ Exámenes0.728989
Physician Data Query0.906997
libre uso0.636785
prevención revisa0.652274
información ayuda0.682663
vías respiratorias0.673206
carcinoma epidermoide0.760269
National Cancer Institute0.66546
cáncer.ampliar esofagoscopía0.714851
siguientes riesgos0.649549
siguientes sumarios0.849506
Instituto Nacional0.740034
CLICK HERE
3438 National Cancer Institute Html es Exámenes de detección del cáncer de estómago (gástrico) (PDQ®)–Versión para profesionales de salud Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de estómago (gástrico).
Offerhaus J0.113586
Cancer Res Clin0.264444
Cancer high-risk subjects0.263357
mass screening0.365942
Leung WK0.124317
Kobayashi K0.11932
American Cancer Society0.823817
detección versus0.189954
case-control study0.112022
Tytgat GN0.125733
CA Cancer0.258236
Instituto Nacional0.144846
PDQ Exámenes0.215492
prospectively followed chinese0.229607
Estados Unidos0.202827
Yanaoka K0.108053
biological agents0.104643
Morson BC0.118473
high risk0.121936
repeated endoscopic screens0.228776
Lancet Oncol0.24929
mass screening program0.337333
mass survey0.121584
Gastrointestinal Tract0.130066
Ma JL0.109737
mass screening techniques0.150063
Precancerous Lesions0.123357
Barbara L0.103989
Cancer Facts0.263557
Pfeiffer R0.11257
Costa Rica0.0971337
detección darán0.220411
Mathus-Vliegen EM0.121366
Ubukata T0.120185
National Cancer Institute0.793771
Oka M0.099234
gastric carcinoma0.217462
Endoscopic screening during0.138672
serum pepsinogen concentrations0.241325
New York0.185957
Clin Oncol0.132653
Kitahara F0.112823
Sherlock P0.239085
X-ray screening seems0.130764
serum pepsinogen0.612986
using serum pepsinogen0.482271
Sato T0.127922
stomach cancer0.944477
Wu MS0.109301
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.